You have 9 free searches left this month | for more free features.

Molgramostim

Showing 1 - 25 of 135

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Autoimmune Pulmonary Alveolar Proteinosis Trial in Worldwide (Molgramostim, Placebo, PARI eFlow nebulizer system)

Completed
  • Autoimmune Pulmonary Alveolar Proteinosis
  • Molgramostim
  • +2 more
  • Los Angeles, California
  • +29 more
Dec 14, 2022

Mycobacterium Infections, Nontuberculous, Cystic Fibrosis (CF) Trial in United States (Molgramostim nebulizer solution, PARI

Terminated
  • Mycobacterium Infections, Nontuberculous
  • Cystic Fibrosis (CF)
  • Molgramostim nebulizer solution
  • PARI eFlow nebulizer system
  • Denver, Colorado
  • +4 more
Oct 10, 2021

Venous Leg Ulcer Trial in Copenhagen (rhGM-CSF + hydrogel, Placebo hydrogel, Standard care)

Active, not recruiting
  • Venous Leg Ulcer
  • rhGM-CSF + hydrogel
  • +2 more
  • Copenhagen, Denmark
    Department of Dermatology and Copenhagen Wound Healing Center, B
Nov 16, 2022

Malignant Ascites Trial (Serplulimab, Molgramostim, Hypofractionated radiotherapy/Sterotactic body radiotherapy)

Not yet recruiting
  • Malignant Ascites
  • (no location specified)
Aug 11, 2022

Mycobacterium Infections, Nontuberculous Trial in Australia, United Kingdom (Inhaled molgramostim)

Completed
  • Mycobacterium Infections, Nontuberculous
  • Inhaled molgramostim
  • Concord, New South Wales, Australia
  • +4 more
Mar 23, 2021

Severe Acute Respiratory Syndrome (SARS) Pneumonia, COVID-19 Pneumonia Trial in Germany (Molgramostim nebuliser solution,

Active, not recruiting
  • Severe Acute Respiratory Syndrome (SARS) Pneumonia
  • COVID-19 Pneumonia
  • Molgramostim nebuliser solution
  • Placebo nebuliser solution
  • Dresden, Germany
  • +8 more
Jun 20, 2022

Autoimmune Pulmonary Alveolar Proteinosis Trial in Worldwide (Molgramostim, Placebo)

Recruiting
  • Autoimmune Pulmonary Alveolar Proteinosis
  • Molgramostim
  • Placebo
  • Little Rock, Arkansas
  • +54 more
Dec 14, 2022

Autoimmune Pulmonary Alveolar Proteinosis Trial in Worldwide (Molgramostim)

Completed
  • Autoimmune Pulmonary Alveolar Proteinosis
  • Molgramostim
  • Århus, Denmark
  • +12 more
Feb 2, 2021

ARDS Trial in Germany (inhaled molgramostim (rhGM-CSF), inhaled )

Active, not recruiting
  • ARDS
  • inhaled molgramostim (rhGM-CSF)
  • inhaled placebo
  • Würzburg, Baden-Würtemberg, Germany
  • +6 more
Oct 27, 2021

Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)

Recruiting
  • Neuroblastoma Recurrent
  • Natural killer cell
  • +4 more
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Feb 22, 2023

Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage

Recruiting
  • Advanced Solid Tumor
  • Refractory Tumor
  • Radiotherapy
  • +4 more
  • Suzhou, China
    The Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023

Advanced Ovarian Cancer Trial in Seattle (AST-201, Paclitaxel, Carboplatin)

Not yet recruiting
  • Advanced Ovarian Cancer
  • AST-201
  • +4 more
  • Seattle, Washington
    University of Washington
Mar 20, 2023

HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

Active, not recruiting
  • HER2-positive Breast Cancer
  • +8 more
  • pNGVL3-hICD vaccine
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022

Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)

Recruiting
  • Neuroblastoma
  • Naxitamab monotherapy
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 31, 2023

Appendicitis Perforated Trial in Copenhagen, Herlev (Combination of fosfomycin, metronidazole and rhGM-CSF (administered

Completed
  • Appendicitis Perforated
  • Combination of fosfomycin, metronidazole and rhGM-CSF (administered together intraperitoneally) and three days of antibiotics p.o.
  • Standard antibiotics intravenously
  • Copenhagen, Denmark
  • +1 more
Oct 14, 2018

Resectable Esophageal Cancer Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Recruiting
  • Resectable Esophageal Cancer
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University
Mar 23, 2022

Hepatitis B, Chronic Trial in Beijing (Granulocyte Macrophage-colony Stimulating Factor, Entecavir)

Terminated
  • Hepatitis B, Chronic
  • Granulocyte Macrophage-colony Stimulating Factor
  • Entecavir
  • Beijing, Beijing, China
    302 Military Hospital
Mar 9, 2022

Renal Cancer Trial in Boston (Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF))

Active, not recruiting
  • Renal Cancer
  • Dendritic Cell Tumor Fusion Vaccine
  • Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 2, 2023

Resectable Pancreatic Cancer Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Recruiting
  • Resectable Pancreatic Cancer
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Nov 15, 2021

Posterior Fossa Ependymoma (PFEPN) Trial in Aurora (Trastuzumab after SubQ GM-CSF, Trastuzumab in combination with SubQ GM-CSF)

Recruiting
  • Posterior Fossa Ependymoma (PFEPN)
  • Trastuzumab after SubQ GM-CSF
  • Trastuzumab in combination with SubQ GM-CSF
  • Aurora, Colorado
    Children's Hospital Colorado
Dec 2, 2021

Advanced Malignant Solid Tumor Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Active, not recruiting
  • Advanced Malignant Solid Tumor
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital
Nov 15, 2021

Pancreatic Cancer, Pancreatic Carcinoma Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Completed
  • Pancreatic Cancer
  • Pancreatic Carcinoma
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Nov 15, 2021

Pediatric Sepsis-induced MODS Trial in United States (GM-CSF)

Active, not recruiting
  • Pediatric Sepsis-induced MODS
  • Los Angeles, California
  • +7 more
Feb 24, 2022

Down Syndrome Trial in Aurora (Sargramostim for Injection, Saline Placebo)

Not yet recruiting
  • Down Syndrome
  • Sargramostim for Injection
  • Saline Placebo
  • Aurora, Colorado
    University of Colorado Anschutz Medical Campus
Jul 28, 2022

Breast Ductal Carcinoma In Situ Trial in Jacksonville, Rochester (Granulocyte-Macrophage Colony-Stimulating Factor,

Recruiting
  • Breast Ductal Carcinoma In Situ
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • +2 more
  • Jacksonville, Florida
  • +1 more
Dec 10, 2021